Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

NCT00360568 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyskinesias
Parkinson's Disease
Severe Motor Fluctuations

Interventions

DRUG: Levodopa-carbidopa intestinal gel
DEVICE: CADD-Legacy® 1400 ambulatory infusion pump
DEVICE: PEG tube
DEVICE: J-tube

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]